[BVDU therapy in herpes corneae].
The authors report on the results of therapy with 0.1% BVDU eye drops in a pilot study involving 80 patients suffering from stellate, dendritic, and geographic keratitis. Tolerance of this drug was very good. Healing occurred in 66 patients (82.5%) within 14 days. In these patients re-epithelialization was complete after an average of 5.4 days. In 13 patients (16.3%) the lesion took more than 14 days to heal (mean 18.2 days). The therapy must therefore be considered as having failed in these cases. In one patient (1.2%) the treatment had to be discontinued, as his condition deteriorated during treatment with BVDU.